IAVARONE, MASSIMO ALBERTO
IAVARONE, MASSIMO ALBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance
2023 P. Biondetti, A.M. Ierardi, E. Casiraghi, A. Caruso, P. Grillo, S. Carriero, C. Lanza, S.A. Angileri, A. Sangiovanni, M. Iavarone, G. Guzzardi, G. Carrafiello
An unprecedented challenge: The north italian gastroenterologist response to COVID-19
2022 G.E. Tontini, G. Aldinio, N. Nandi, A. Rimondi, D. Consonni, M. Iavarone, P. Cantu, A. Sangiovanni, P. Lampertico, M. Vecchi
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy
2021 V. Burgio, M. Iavarone, G.G. Di Costanzo, F. Marra, S. Lonardi, E. Tamburini, F. Piscaglia, G. Masi, C. Celsa, F.G. Foschi, M. Silletta, D.C. Amoruso, M. Rimini, M. Bruccoleri, R. Tortora, C. Campani, C. Solda, M.G. Viola, A. Forgione, F. Conti, F. Salani, S. Catanese, C.M. Giacchetto, C. Fulgenzi, C. Coppola, P. Lampertico, A. Pellino, G. Rancatore, G. Cabibbo, F. Ratti, F. Pedica, A. Della Corte, M. Colombo, F. De Cobelli, L. Aldrighetti, S. Cascinu, A. Casadei-Gardini
Interventional radiology image-guided locoregional therapies (Lrts) and immunotherapy for the treatment of hcc
2021 P. Biondetti, L. Saggiante, A.M. Ierardi, M. Iavarone, A. Sangiovanni, F. Pesapane, E.M. Fumarola, P. Lampertico, G. Carrafiello
Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature
2021 E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi, E. Palomba, M. Maggioni, G. Viero, D. Mangioni, R. Lombardi, B. Antonelli, D. Dondossola, M. Iavarone, A.L. Fracanzani, A. Bandera, A. Gori, A. Lombardi
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL) : a randomised, controlled, phase 2b/3 trial
2020 V. Mazzaferro, D. Citterio, S. Bhoori, M. Bongini, R. Miceli, L. De Carlis, M. Colledan, M. Salizzoni, R. Romagnoli, B. Antonelli, M. Vivarelli, G. Tisone, M. Rossi, S. Gruttadauria, S. Di Sandro, R. De Carlis, M.G. Luca, M. De Giorgio, S. Mirabella, L. Belli, S. Fagiuoli, S. Martini, M. Iavarone, G. Svegliati Baroni, M. Angelico, S. Ginanni Corradini, R. Volpes, L. Mariani, E. Regalia, M. Flores, M. Droz dit Busset, C. Sposito
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19
2020 M.A. Iavarone, R. D'Ambrosio, P. Lampertico
Hepatic fat - genetic risk score predicts hepatocellular carcinoma in HCV cirrhotic patients treated with DAAs
2020 E. Degasperi, E. Galmozzi, S. Pelusi, R. D'Ambrosio, R. Soffredini, M. Borghi, R. Perbellini, F. Facchetti, M. Iavarone, A. Sangiovanni, L. Valenti, P. Lampertico
Experience Wwith Early Sorafenib Treatment with Mtor Inhibitors in Hepatocellular Carcinoma Recurring after Liver Transplantation
2019 F. Invernizzi, M. Iavarone, C. Zavaglia, S. Mazza, U. Maggi, L. Cesarini, B.B. Antonelli, A. Airoldi, M.A. Manini, A. Sangiovanni, G. Rossi, M.F. Donato, L.S. Belli, P. Lampertico
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation
2019 M. Iavarone, F. Invernizzi, C. Czauderna, M. Sanduzzi-Zamparelli, S. Bhoori, G. Amaddeo, M.A. Manini, M. Fraile López, M. Anders, M. Pinter, M.J. Blanco Rodríguez, M. Romero Cristóbal, G. Aballay Soteras, F. Piñero, G.E. Villadsen, A. Weinmann, G. Crespo, V. Mazzaferro, H. Regnault, M. De Giorgio, M.L. González-Diéguez, M.F. Donato, M. Varela, M. Wörns, J. Bruix, P. Lampertico, M. Reig
Multimodality treatment of hepatocellular carcinoma : How field practice complies with international recommendations
2018 A. Sangiovanni, M. Triolo, M. Iavarone, L.V. Forzenigo, A. Nicolini, G. Rossi, V. La Mura, M. Colombo, P. Lampertico
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics
2018 M. Iavarone, M. Viganò, C. Orcese, M. Coen, C. Oggioni, A. Spinetti, A. Soria, C. Galli, C. Tagliacarne, L. Scaramella, M. Merli, R. Rossotti, G. Gubertini, S. Merli, A. Piscitelli, A. Comelli, V. Castelli, D. Cereda, M. Gramegna, M. Puoti, A. Gori, M.G. Rumi, F. Castelli, P. Lampertico, L. Romanò
High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis
2018 E. Arsiè, S. Piconi, M. Iavarone, V. Cozzi, P. Lampertico, D. Cattaneo
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B
2018 A. Loglio, M. Iavarone, G. Grossi, M. Viganò, M.G. Rumi, F. Facchetti, G. Lunghi, A. Sangiovanni, M. Colombo, P. Lampertico
Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib
2016 M. Iavarone, M. Primignani, S. Vavassori, A. Sangiovanni, V. La Mura, R. Romeo, M. Colombo
A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene
2015 A. El Shamy, F.J. Eng, E.H. Doyle, A.L. Klepper, X. Sun, A. Sangiovanni, M. Iavarone, M. Colombo, R.E. Schwartz, Y. Hoshida, A.D. Branch
Cholangiocarcinoma in Cirrhosis : Value of Hepatocyte Specific Magnetic Resonance Imaging
2015 F. Piscaglia, M. Iavarone, M. Galassi, S. Vavassori, M. Renzulli, L.V. Forzenigo, A. Granito, V. Salvatore, A. Sangiovanni, R. Golfieri, M. Colombo, L. Bolondi
TACE with drug-eluting beads is effective for the maintenance of the milan-in status in patients with a small hepatocellular carcinoma
2015 M.A. Manini, A. Sangiovanni, L. Martinetti, D. Viganò, V. La Mura, A. Aghemo, M. Iavarone, S. Crespi, A. Nicolini, M. Colombo
Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
2015 M. Iavarone, G. Cabibbo, M. Biolato, C. Della Corte, M. Maida, M. Barbara, M. Basso, S. Vavassori, A. Craxì, A. Grieco, C. Cammà, M. Colombo
A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration
2015 L.Y. King, C. Canasto Chibuque, K.B. Johnson, S. Yip, X. Chen, K. Kojima, M. Deshmukh, A. Venkatesh, P.S. Tan, X. Sun, A. Villanueva, A. Sangiovanni, V. Nair, M. Mahajan, M. Kobayashi, H. Kumada, M. Iavarone, M. Colombo, M.I. Fiel, S.L. Friedman, J.M. Llovet, R.T. Chung, Y. Hoshida